Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Vivo Capital

Albert Cha And Frank Kung

1,618,296 $30,731 +10% 1.37%
2.
Ikarian Capital

Neil Shahrestani

1,063,961 $20,204 -14% 0.89%
3.
Logos Capital

Arsani William

490,000 $9,305 +64% 0.79%
4.
Opaleye Management

James A. Silverman

470,203 $8,929 1.16%
5. 308,900 $5,866 0.08%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.34 47,431 Director 1,138,179 2020-10-30 Filing
$17.17 68,255 Director 1,090,748 2020-10-30 Filing
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.87 500 Officer 47,969 2021-02-23 Filing
$32.94 3,311 Officer 48,469 2021-02-23 Filing
$33.74 10,389 Officer 51,780 2021-02-23 Filing
$35.39 800 Officer 62,169 2021-02-23 Filing
$31.77 1,256 Officer 65,000 2021-02-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,957 $56,153 0%
2. 1,680,000 $31,903 0.48%
3. 1,640,278 $31,149 0%
4. 1,719,576 $25,679 12.37%
5. 1,113,380 $21,143 0%
News See All